NewslettersPulmonary Cell NewsInhibitor of PD-1/PD-L1: A New Approach May Be Beneficial for the Treatment of Idiopathic Pulmonary FibrosisBy Laurisa Dohm - February 6, 20240217The authors discuss the application of PD-1/PD-L1 checkpoint in idiopathic pulmonary fibrosis, with the aim of finding a new direction for idiopathic pulmonary fibrosis treatment.[Journal Of Translational Medicine]Full Article